Liwagon, Bb Boy .
HRN: 25-76-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/31/2024
09/07/2024
IV
55mg
Q24h
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes